Contact lenses

... IRIDEX CEO Barry Caldwell Nominated to Stand for Election to STAAR Surgical Board of Directors IRIDEX CEO Barry Caldwell Nominated to Stand for Election to STAAR Surgical Board of Directors MONROVIA, Calif., April 17 /PRNewswire-FirstCall/ - STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that Barry G.

Caldwell, President and CEO of IRIDEX Corporation, (Nasdaq: IRIX) will stand for election to its Board of Directors at STAAR's annual shareholder's meeting on May 16, 2007.

He has been nominated to serve in a new seat created to increase the size of STAAR's board to six members.

"We are delighted that Barry has agreed to stand for election to STAAR Surgical's Board of Directors.

If elected by our shareholders, he will bring more than 30 years of general management, sales and corporate business development experience in the ophthalmic industry," said Don Bailey, Chairman of the Board of Directors at STAAR Surgical.

"Barry's industry expertise will be an asset to our company as we continue to grow our worldwide refractive business, and we believe he will bring a unique and relevant perspective to our Board." Prior to joining IRIDEX in 2005 as the Company's President, CEO and a member of its Board of Directors, Mr.

Caldwell, (56), served in various leadership capacities with Alcon Laboratories, Inc., a leading developer, manuf...

Read more...